Industry Providers Related News

Synthego Announces Modified Synthetic sgRNA for CRISPR Genome Editing

Synthego, a leading provider of genome engineering solutions headquartered in Silicon Valley, announced today a new product line in the CRISPRevolution product family: chemically modified synthetic guide RNA, including modified full length 100-mer synthetic single guide RNA (sgRNA). Applications of [...]

By | March 21st, 2017|DNA Synthesis, Industry Providers, News|

Thermo Fisher Scientific Announces First-Ever Cloud-Based Application for Connectivity to Electronic Pipettes

WALTHAM, Mass.--(BUSINESS WIRE) Wednesday, March 15, 2017 8:30 am EDT --Life science researchers working across many applications can now benefit from the first-ever web-based pipetting application, developed to enable seamless connectivity with electronic pipettes for optimized performance and safe, efficient [...]

Synpromics Granted Key Patent in Synthetic Promoter Development

Edinburgh, UK, 16th March 2017 / Sciad Newswire / Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce it has been granted a key patent (EP2668277B1) by the European Patent Office, protecting PromPT™ - its proprietary synthetic [...]

By | March 16th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

Eurofins Genomics US Announces Commercial Launch of Next Generation DNA Synthesis Service

LOUISVILLE, Ky., March 14, 2017 /PRNewswire/ -- Eurofins Genomics, the pioneer of high-throughput oligonucleotide synthesis, announced the U.S. commercial launch of a unique DNA synthesis service based on the company's revolutionary next-generation synthesis platform. The service, which is designed to [...]

By | March 16th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

BioBright Tools Bring ‘Superpowers’ to the Biology Lab

March 14, 2017 09:00 AM Eastern Daylight Time  BOSTON--(BUSINESS WIRE)--BioBright, a firm developing technologies to enable more precise, more reproducible research protocols in biology, has improved the accuracy of a delicate laboratory technique by more than 20 times in the [...]

Horizon Discovery enters into R&D and licensing partnership with Amplycell S.A. for bioproduction cell line optimisation

Cambridge, UK and Liege, BE, 8 March 2017 - Horizon Discovery Group plc (LSE: HZD) ("Horizon"), the world leader in the application of gene editing technologies, including the provision of bioproduction cell lines, today announced it has entered into a research and [...]